MADRID – Results from a phase III trial of a new drug, TAS-102, that mimics the action of fluorouracil showed that it significantly boosted overall survival in heavily pretreated patients with...
MADRID – Results from a phase III trial of a new drug, TAS-102, that mimics the action of fluorouracil showed that it significantly boosted overall survival in heavily pretreated patients with...
SAN FRANCISCO – Only a fraction of patients with breast cancer who are eligible for neoadjuvant therapy are getting it, partly because of confusion around the significance of achieving a pathologic...
SAN FRANCISCO – Only a fraction of patients with breast cancer who are eligible for neoadjuvant therapy are getting it, partly because of confusion around the significance of achieving a pathologic...
SAN FRANCISCO – Physicians have multiple good reasons to suggest lifestyle changes to many patients with breast cancer, but affecting the cancer itself may not be one of them, Dr. Pamela J. Goodwin...
SAN FRANCISCO – Physicians have multiple good reasons to suggest lifestyle changes to many patients with breast cancer, but affecting the cancer itself may not be one of them, Dr. Pamela J. Goodwin...
CHICAGO – Women with breast cancer and bone metastasis can safely scale back the frequency of their zoledronic acid infusions from every 12 weeks to every 4 weeks without a loss in efficacy,...
CHICAGO – Women with breast cancer and bone metastasis can safely scale back the frequency of their zoledronic acid infusions from every 12 weeks to every 4 weeks without a loss in efficacy,...